Clinical Studies to Reveal Skin Health Benefits of Hydrolyzed Collagen
Rousselot objectives were to precisely measure the effect of daily oral intake of 10g Peptan Hydrolyzed Collagen on skin and to evaluate its acceptability by users. The trials were performed in a 3 month period.
21/04/09 Since the end of 2008, two clinical studies involving women in Japan and France have been commissioned by Rousselot to measure the effectiveness of Peptan Hydrolyzed collagen on skin health as well as subjective assessment.
Rousselot objectives were to precisely measure the effect of daily oral intake of 10g Peptan Hydrolyzed Collagen on skin and to evaluate its acceptability by users. The trials were performed in a 3 month period.
The double-blind randomized clinical studies versus placebo were carried on 80 healthy female subjects aged of 35 to 59. They were carried out by Dermscan in France and Souken in Japan, two global independent research organizations specialized in cosmetics and nutrition, having a unique approach for verifying product performance claims. Certified skin experts selected volunteers and assessed the mechanical measurements.
Moisturizing and anti aging effects as well as tolerance were measured using leading edge technologies and methods. Researchers come to the following conclusions: the results verify that regular intake of Peptan Hydrolysed Collagen improves the basic skin condition and structure: the skin is better hydrated, the number of micro relief furrows are reduced and the formation of deep wrinkles is prevented.
At 2009 Vitafoods trade fair (stand 348), Rousselot will present detailed figures resulting from these studies and will demonstrate the extent to which Peptan hydrolyzed collagen represents a very potent nutricosmetic ingredient that contributes to healthier skin.
Rousselot looks forward to receiving visitors at stand 348 where they will discover and enjoy the different Peptan formulae. Rousselot (part of the Vion Group) is a leading manufacturer of gelatine and hydrolyzed collagen to the food, pharmaceutical and technical industries.
